https://www.washingtonpost.com/business/2020/05/26/remdesivir-coronavirus-taxpayers/
Gilead plans to invest $1B in 2020 for remdesivir manufacturing. Process to get approval as a treatment for COVID-19 costing tens of millions, but US taxpayers footing the bill for that.
Perhaps the opportunity before us with hinokitiol on top of everything else warrants a significant capital raise. $50m in a Nasdaq IPO for 10% of the company? This would also solve the stock's liquidity issue, imo.
- Forums
- ASX - By Stock
- Ann: Business Update
https://www.washingtonpost.com/business/2020/05/26/remdesivir-cor...
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ANO (ASX) to my watchlist
|
|||||
Last
72.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $44.96M |
Open | High | Low | Value | Volume |
72.0¢ | 72.0¢ | 72.0¢ | $14.59K | 20.26K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 22500 | 72.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
73.0¢ | 159 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 22500 | 0.720 |
1 | 50 | 0.250 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.730 | 159 | 1 |
0.745 | 568 | 1 |
0.750 | 3600 | 2 |
0.790 | 500 | 1 |
0.800 | 6001 | 1 |
Last trade - 11.53am 19/08/2024 (20 minute delay) ? |
Featured News
ANO (ASX) Chart |